A clinician-guided peptide program focused on the immune-response pathway.
Thymosin Alpha-1, also called TA-1, is a peptide that has been studied for its interaction with several parts of the immune system. Rather than being positioned as a treatment for a specific illness, the program is for adults who want to discuss whether this immune-focused peptide may fit their health goals.
At Drip Lounge, Thymosin Alpha-1 is not selected from a catalog or started without review. Your health history, medications, goals, and eligibility are reviewed before a provider determines whether the program is appropriate.
Disclaimer: A consultation is required before treatment. Thymosin Alpha-1 is not FDA-approved as a wellness treatment in the United States. Compounded drugs are not FDA-approved. FDA has also identified concerns regarding compounded TA-1, including immunogenicity and peptide-related impurities. Always consult a licensed healthcare provider.
Cancellations or reschedules must be made at least 24 hours in advance or the full amount will be forfeited.